Correlación entre microbiota intestinal y trastornos neurológicos
DOI:
https://doi.org/10.33233/eb.v22i6.5570Palabras clave:
Eje intestino-cerebro, Influencia humoral de la microbiota, Desórdenes neurológicosResumen
La microbiota intestinal, compuesta por una diversidad de microorganismos, desempeña un papel crucial en la digestión, absorción de nutrientes y en la salud general del huésped. Su composición varía según factores individuales como la dieta, la edad, la genética y el entorno. A pesar de la comprensión de la influencia de los intestinos en la producción de hormonas como la serotonina, los efectos de las alteraciones en la microbiota en el sistema nervioso aún no están completamente esclarecidos. Este artículo explora los recientes descubrimientos científicos sobre este eje intestino-cerebro, enfatizando diversos estudios que han investigado los efectos de la microbiota intestinal en el comportamiento y el sistema nervioso central.
Citas
Lanxiang Liu, Haiyang Wang, Xueyi Chen, Peng Xie. Gut microbiota: a new insight into neurological diseases. Chin Med J. 2023;136(11):1261-77. doi: 10.1097/CM9.0000000000002212
Murakami T, Kamada K, Mizushima K, Higashimura Y, Katada K, Uchiyama K, et al. Changes in intestinal motility and gut microbiota composition in a rat stress model. Digestion. 2017;95(1):55-60. doi: 10.1159/000452364
Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. doi: 10.1152/physrev.00018.2018
Faulin T, Estadella D. Alzheimer’s disease and its relationship with the microbiota-gut-brain axis. Arq gastroenterol. 2023.;60(1). doi: 10.1590/S0004-2803.202301000-17
Nannan Li, Qi Wang, Yan Wang, Anji Sun, Yiwei Lin, Ye Jin, Xiaobai Li, et al.. Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress. 2019;22(5):592-602. doi: 10.1080/10253890.2019.1617267
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019;5(2):eaau8317. doi: 10.1126/sciadv.aau8317
Mejía-Granados DM, Villasana-Salazar B, Coan AC, Balthazar MLF, Godoi AB, Canto AM, et al. Gut microbiome in neuropsychiatric disorders. Arq Neuro-Psychiatr. 2022;80(2). doi: 10.1590/0004-282X-ANP-2021-0052
Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, et al. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine. 2019;44:691-707. doi: 10.1016/j.ebiom.2019.05.064
Glover ME, Cohen JL, Singer JR, Sabbagh MN, Rainville JR, Hyland MT, et al. Examining the role of microbiota in emotional behavior: antibiotic treatment exacerbates anxiety in high anxiety-prone male rats. Neuroscience. 2021;459:179-97. doi: 10.1016/j.neuroscience.2021.01.030
Ping Liu, Li Wu, et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain, Behavior, and Immunity 2019;80:633-43. doi: 10.1016/j.bbi.2019.05.008
Vogt NM, Kerby RL, et al. Gut microbiome alterations in Alzheimer’s disease. Scientific Reports. 2017;7:13537. [acesso em 25 ago 2023]; Disponível em: https://www.nature.com/articles/s41598-017-13601-y
Chunxiao Li, Li Cui et al. Gut microbiota differs between parkinson’s disease patients and healthy controls in Northeast China. Front Mol Neurosci. 2019;12. doi: 10.3389/fnmol.2019.00171
Arora K, Green M, Prakash S. The microbiome and Alzheimer's Disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Front Bioeng Biotechnol. 2020;8:537847. doi: 10.3389/fbioe.2020.537847
Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N and Bahari H. Probiotics for Alzheimer's disease: a systematic review. Nutrients. 2021;14(1):20. doi: 10.3390/nu14010020
Cekanaviciut E, Yoo BB, Runia TF, Baranzini SE, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. PNAS. 2017;114(40):10713-18. doi: 10.1073/pnas.1711235114
Cantarel BL, Waubant E, et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. Journal of Investigating Medicine. 2015 ;63(5):729-34. doi: 10.1097/JIM.0000000000000192
Keshavarzian A, Green SJ, et al. Colonic bacterial composition in Parkinson's disease. Movement Disorders. 2015;10:1351-60. doi: 10.1002/mds.26307
Aho VTE, Houser MC, at al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease. Molecular Neurodegeneration. 2021;16:6. doi: 10.1186/s13024-021-00427-6
Na Li, Xingcui Wang, et al. Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiology. 2019;19:191. doi: 10.1186/s12866-019-1552-1
Kihyun Lee, Namil Kim at al. Gut bacterial dysbiosis in children with intractable epilepsy. J Clin Med. 2021;10(5). doi: 10.3390/jcm10010005
Anjiao Peng, Xiangmiao Qiu, et al. Altered composition of the gut microbiome in patients with drug-resistant epilepsy. Epilepsy Research. 2018;147:102-07. doi: 10.1016/j.eplepsyres.2018.09.013
Publicado
Número
Sección
Licencia
Derechos de autor 2024 Clara de Almeida e Araujo Leite , Juan Pablo Lemos dos Santos , Luciana Armada, Marco Antonio Araujo Leite, Catarine Torquato Barcellos , Marco Orsini
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
